FIELD: medicine.
SUBSTANCE: claimed group of inventions relates to medicine, namely to neurology, and deals with treatment of organic diseases of the nervous system, including psychoorganic syndrome and encephalopathies of different genesis. For this purpose a pharmaceutical composition, which contains an activated potentiated form of antibodies to brain-specific protein S-100 and an activated potentiated form of antibodies to endothelial NO-synthase, is introduced.
EFFECT: invention provides efficient treatment of organic disease of the nervous system due to the synergic action of the composition components.
11 cl, 5 ex, 5 tbl
Authors
Dates
2014-10-10—Published
2010-07-21—Filed